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Abstract
Photodynamic therapy (PDT) uses photosensitisers such as protoporphyrin IX (PpIX) to tar-
get tumours via the release of toxic singlet oxygen when irradiated. The effectivity of the
treatment is limited by the innate properties of the photosensitizers; they typically exhibit
inefficient accumulation in target tissue and high dark toxicity. Carbon dots (CDs) are bio-
compatible fluorescent nanoparticles which can improve PpIX cellular uptake and solubility.
In this work, we present conjugates synthesised by host-guest encapsulation (PpIX@CD)
and amide cross-linking (PpIX-CD). Characterization demonstrated conjugates have a load-
ing efficiency of 34–48% and similar singlet oxygen production to PpIX. PpIX-containing
CDs showed a 2.2 to 3.7-fold decrease in dark toxicity. PpIX-CD and PpIX@CD showed
equivalent light-induced toxicity to PpIX in concentrations !1 ȝg/ml, leading to a 3.2 to 4.1-
fold increase in photo-toxicity index (PI). The less soluble fraction of cross-linked conjugates
(PpIX-CD)p did not show significant difference from PpIX. Confocal light scanning micros-
copy demonstrated rapid intracellular uptake and accumulation of conjugates. Our results
demonstrate the variations between cross-linking strategies in CD-based conjugates,
highlighting their potential as carriers in drug delivery and bioimaging applications.
Introduction
Photodynamic therapy (PDT) has seen advances in recent years as an alternative cancer treat-
ment due to its non-invasive nature, specificity and selectivity [1]. The term “PDT” describes a
range of protocols based on the excitation of photosensitizers (PS) in the presence of oxygen to
singlet oxygen (1O2) leading to tumour ablation [2]. PDT has been proven to be clinically effec-
tive presenting positive results in basal cell carcinoma, endobronchial lung cancer, and non-
muscle invasive bladder cancer [3–5]. Highly controlled light dosimetry and rapid drug uptake
maximizes the effectiveness of the treatment and prevents damage to surrounding tissue [6].
Nanoparticle-photosensitizer conjugates have received increased interest due to several
advantages such as; (i) large surface-volume ratios for increased loading efficiency, (ii) the for-
mation of amphiphilic compounds to avoid aggregation, and (iii) the enhanced permeability
and retention effect for increased accumulation in tumours due to “leaky” vasculature [7–9].
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Moreover, conjugates can also function as bioimaging probes to form multifunctional therag-
nostics platforms through photodynamic diagnosis (PDD) [10]. Porphyrins are naturally-
occurring heterocyclic molecules composed of pyrrole rings connected by methylylidene
bonds. These molecules are found in living organisms acting as electron and oxygen transport-
ers or metalloenzymes through the chelation of metal ions by coordination.
Protoporphyrin IX (PpIX) is a well-characterised endogenous porphyrin photosensitizer,
normally present in minor concentrations within cells as part of the heme biosynthesis path-
way. Dormant cancer cells have been proven to accumulate high concentrations of PpIX and
are more susceptible to PDT [11]. However, PpIX is limited as a photosensitizer mainly due to
elevated dark toxicity and rapid aggregation. This which leads to decreased photoactivity as
singlet oxygen production is attenuated [12,13]. Recent advances have focused on utilising car-
riers and chemical modifications to improve water solubility and increase cellular viability
[14]. For example, Homayani et al. (2015) demonstrated that hydroxyl-group modification
can increase the water solubility of PpIX, reducing dark toxicity and increasing cellular uptake
[15].
Carbon dots (CDs) are carbon-based fluorescent nanoparticles that have gained attention
due to their interesting photophysical properties, low toxicity, tuneable surface functionality
and adaptable synthesis making them ideal candidates for drug delivery, bioimaging, and ther-
anostics applications. [16–19]. CDs have shown similar success in biomedical applications in
comparison to other nanomaterials such as semiconductor quantum dots, nanodiamonds, gra-
phene, and carbon nanotubes. Nanoparticle-based drug delivery has been shown to improve
intracellular drug uptake and reduce the likelihood of cargo degradation. [20]. The rapid intra-
cellular uptake of CDs and CD-based conjugates has been shown to be time and dose-depen-
dent and is a combination of both passive uptake and caveolae and clathrin-mediated
endocytosis [21]. Moreover, CDs can be further modified by doping with heteroatoms and
surface passivation with a variety of molecules such as polyethylene glycol to achieve better
photophysical properties [22]. CDs have previously been used as carriers for a wide variety of
compounds, including doxorubicin, rhodamine B, dsDNA, siRNA and ciprofloxacin hydro-
chloride [23–27].
CDs have tuneable photoluminescence ranging across the visible spectrum which depends
on their synthesis conditions, affecting quantum yield, determining excitation-dependent or
independent emission, and type of photoluminescence decay [28]. In vitro studies demonstrate
rapid intracellular uptake and do not show significant toxicity even at extremely high concen-
trations [29]. In vivo and ex vivo imaging in BALB/c mice show similar results with no observ-
able toxicity and rapid clearance from the reticuloendothelial system [30]. Furthermore, CDs
have previously demonstrated comparable two-photon cross-sections to those of commer-
cially-available quantum dots, making them highly valuable as probes for bioimaging applica-
tions [31].
Recently, CD-PS cross-linking has recently gained research interest. CDs have extremely
high surface area to volume ratios which make them ideal candidates for drug loading and
cross-linking. Amide cross-linking is a well-known cross-linking strategy which relies on
interactions between carboxyl and primary amine groups. EDC (1-ethyl-3-(3-dimethylamino)
propyl carbodiimide) is a zero-length cross-linker that can be used alongside N-hydroxysucci-
nimide (NHS) to efficiently produce amide bonds between two suitable molecules [32]. Photo-
sensitizers such as chlorin e6, Rose Bengal and PpIX have been previously covalently linked
through carbodiimide chemistry, the latter of which showed a PDT effect under two-photon
excitation [33–35]. Similarly, recent advances have shown embedded photosensitizers are
capable of singlet oxygen production while embedded on nanoparticles [36,37]. Host-guest
embedding reduces the complexity and costs of synthesis while retaining drug loading.
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In this study, we present PpIX@CD, a CD-based conjugate synthesized through a one-step
microwave synthesis route. PpIX-CD was synthesized through an adapted carbodiimide cross-
linking protocol. The less soluble fraction (PpIX-CD)p was recovered during sample purifica-
tion of cross-linked conjugates and evaluated against PpIX-CD and PpIX@CD. Singlet oxygen
production was observed for all samples with phenalenone as a standard. The aim of this study
is to compare the photophysical properties and in vitro toxicity of PpIX-CD, (PpIX-CD)p and
PpIX@CD to PpIX in human melanoma (C8161) monolayer cell cultures and determine the
optimal drug loading strategy for increasing PDT efficiency. Conjugates were also evaluated as
bioimaging probes in human osteosarcoma (U2-OS) using confocal laser scanning
microscopy.
Experimental
Materials
Citric acid monohydrate, sucrose, ethylenediamine, protoporphyrin IX, sodium chloride, resa-
zurin sodium salt, (N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide), N-Hydroxysuccini-
mide, formaldehyde, phenalenone, 2-(N-Morpholino) ethanesulfonic acid, acetone, dimethyl
sulfoxide, 2-mercaptoethanol and N,N-dimethylformamide were acquired from Sigma Aldrich
(United Kingdom). Dulbecco’s Modified Eagle’s Medium (DMEM, high glucose), Dulbecco’s
Modified Eagle’s Medium (DMEM, high glucose, without phenol red), fetal bovine serum
(FBS), phosphate buffer saline (PBS), and trypsin–ethylenediaminetetraacetic acid solution
were obtained from Thermo Fisher (United Kingdom). Syringe filters with a 0.2 μm pore size
were acquired from Sarstedt (United Kingdom). 1 KDa MWCO, 6.4 ml/cm dialysis tubing was
acquired from Spectrum Labs (United States of America). All chemicals were used as received
unless stated otherwise. Deionized water was used for all buffers and samples in experiments.
Septa steel ring caps and 35 ml glass reaction vessels were obtained from CEM Corporation
(United Kingdom).
Sample preparation
CA-EDA CDs were synthesized utilising 5 g of citric acid and 1.25 g of EDA dissolved in 100
ml of deionized water and stirred until no visible precipitate remained. This process was
repeated for S-EDA CDs with 5 g of sucrose and 1.25 g EDA. A separate solution was used in
host-guest embedding (PpIX@CD), with 0.5 mg/ml protoporphyrin IX, 5 g of citric acid and
1.25 g EDA in deionized water. A CEM Discover SP microwave reactor was used to heat the
precursor solutions for 5 minutes at constant 150˚C (200 Wmaximum power and 17 bar
threshold). The resulting yellow-coloured solution was cooled to room temperature and cen-
trifuged to remove debris at 5000 rotations per minute (rpm) for 30 minutes. Samples were
dialysed against deionised water with a 1 KDa MWCOmembrane for 48 hours, changing the
buffer at six-hour intervals. Freeze drying was used to remove all liquids from the solutions
(-10˚C shelf temperature, -70˚C collector, 48 hours, 0.1 mbar). The remaining powder was
weighed and stored for further use at 4˚C.
Amide cross-linking of CDs and PpIX
A 4 mg/ml PpIX solution was prepared by dissolving the powder in 25 ml N,N-dimethylfor-
mamide and stirred for 30 minutes at room temperature, keeping it in the dark. Afterwards,
25 mg (N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide) and 50 mg N-Hydroxysuccini-
mide were added and kept stirring for an additional 30 minutes until no precipitate could be
seen. Subsequently, 100 mg of CDs were dissolved in 25 ml PBS and added to the previous
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solution. The solution was stirred overnight and centrifuged, separating the less soluble precip-
itate (PpIX-CD)p. The solutions were dialysed against deionised water using a 1 KDa MWCO
membrane for 48 hours, changing the buffer at six-hour intervals or when a visible colour
change could be observed. Finally, samples were freeze-dried and stored at 4˚C. A stock solu-
tion of conjugates was prepared at a concentration of 1 mg/ml utilising deionised water. The
stock solutions were kept frozen at—20˚C until used.
Conjugate characterization
Transmission electron microscopy (TEM) was used to obtain high-magnification images uti-
lising 1 μg/ml solutions of conjugates that were previously processed with the ultrasonic probe.
Samples were observed on carbon coated grids by a FEI Tecnai G2 Spirit TEM. Individual par-
ticles were counted and measured to determine average particle size. Ultraviolet-visible spec-
troscopy (UV-Vis) was carried out utilising a PerkinElmer Lambda 900 spectrometer in the
range of 250 to 750 nm. Fluorescence spectra were recorded with a Fluoromax 4 fluorometer
utilising 405 nm excitation wavelength, 0.5 nm path length, and 0.5 nm increments from 415
to 750 nm. PpIX loading was calculated by fluorescence comparisons as reported previously
[38]. A sample concentration of 1 μg/ml conjugate in deionised water was utilized for both
spectroscopies. Fourier-transform infrared spectroscopy (FTIR) was used to obtain spectra
with a Nicolet iS50R FT-IR in photoacoustic mode; samples were scanned 512 times in the
range of 450 to 3500 cm-1. X-ray photoelectron spectroscopy (XPS) analysis was carried out
with a monochromated Al-kċ X-ray source, two analysis points per sample and a total scan
area of 700 x 300 μm using an Axis Ultra DLD system (Kratos Analytical, United Kingdom). 5
mg of conjugate powder samples were mounted on between indium foil and a paper label to
mitigate the risk of differential charging. Survey scans were collected in the range of 1200 to 0
eV binding energy (160 eV pass energy, 1 eV intervals, and 300 seconds per sweep–with 4
sweeps collected). High-resolution C1s spectra were collected at 20 eV pass energy and 0.1 eV
intervals. The influence of indium foil on each sample was removed taking into account a sur-
face composition of 26.8 at% O, 19.4 at% In, and 53.8 at% C.
Singlet oxygen production
PpIX, PpIX-CD, (PpIX-CD)p, PpIX@CD, and PNP were dissolved in DMF and the solution
absorbance was adjusted to 0.1–0.12. The solutions were covered in aluminium foil to prevent
photobleaching. A Nd: YAG 355 nm laser was used to excite the solutions at 50, 100 and 200
mJ. Phenalenone was utilized as a control to indicate 100% production. The characteristic fluo-
rescence of singlet oxygen (in the range of 1160–1380 nm) was resolved and collected with an
infrared-sensitive photomultiplier as previously reported [39].
Evaluation of cytotoxicity
Nanoparticle-supplemented DMEM was prepared utilising a stock solution of each conjugate,
at concentrations from 1–100 μg/ml. All solutions were subjected to ultrasonic processing
with a Hieschler UP50H ultrasonic probe and filter sterilised prior to use in cell culture.
Growth media was prepared utilising phenol red-free DMEM with the following: 10% fetal calf
serum, 1% antibiotics (penicillin and streptomycin) and 1% glutamine. C8161 melanoma cells
were used from passage 10 to 20 and were cultured in a T75 plate 5% CO2 at 37˚C, until reach-
ing approximately 90% confluence. Afterwards, cells were diluted to 6 × 104 cells/ml; each well
of a 96-well plate was seeded with 100 μl of cell suspension and placed in the incubator over-
night to allow attachment.
Carbon dot conjugates improve protoporphyrin IX efficiency
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Dark toxicity. Growth medium was replaced with 100 μl of conjugate dilutions (1–
100 μg/ml) and DMEM was added to untreated cells to act as a control. The plates were cov-
ered and returned to the incubator for an additional 24 hours. After incubation, each well was
washed with PBS and 200 μl growth media was replaced prior to the metabolic activity assay.
Light-activated toxicity. Growth medium was replaced with 100 μl of conjugate dilutions
(1–10 μg/ml) and DMEM was added to untreated cells to act as a control. Cells were returned
to the incubator for 3 hours to allow particle internalization. Afterwards, all wells were washed
using PBS and 200 μl phenol red-free media was added. A M405L2 ThorLabs mounted LED
with a collimator adapter (405 nm, 2.76 mW/cm2) was used to induce light-activated toxicity.
Cells were placed under illumination for 3 minutes and subsequently returned to the incuba-
tor. Metabolic activity measurements were taken at 24, 48 and 72-hour time points (post light
activation).
Metabolic activity assay. A 1 mM resazurin solution was prepared by dissolving 25.18 mg
of resazurin sodium salt in 100 ml sterile PBS. The solution was filter sterilized using a 0.2 μm
syringe filter. 100 μl of media was taken from each well and transferred to a new plate. Meta-
bolic activity was assessed by adding 20 μl to each well. The plates were read using a Biotek
ELx808 Microplate Reader at 570/585 nm with a sensitivity of 50. Conjugate LD50 values were
obtained and converted into PpIX-adjusted concentrations (μM) based on the previous esti-
mated PpIX content of each sample.
Confocal light scanning microscopy
Preparation of samples. Fluorescence images were obtained using a Zeiss LSM510 Meta
confocal microscope fitted with a two-photon Ti-Sapphire laser. U2-OS cells were seeded in
six-well tissue culture plates at a density of 1 × 105 cells per well. Cells were placed in the incu-
bator for 2 hours to allow cell attachment. A 1 μg/ml solution of each conjugate was prepared.
Wells were washed with PBS and growth media was replaced with 2 ml of conjugate solution.
The plate was returned to the incubator for 30 minutes. Immediately afterwards the wells were
washed with PBS and fixed using 3.7% formaldehyde and 300 nM 40,6-diamidino-
2-phenylindole.
Image acquisition. Images were obtained using 488 nm (15%), 543 nm (15%) and 800
nm (6.5%) laser lines. Confocal light scanning microscopy was performed using an Achroplan
40×/0.75 N.A. water immersion objective. Z-stacks were defined as a 210.4 ×210.4 × 7.2 μm
area with a pixel time of 51.2 μs.
Statistical analysis
Experiments carried out with three independent repeats in triplicates (N = 3, n = 3) and results
were normalized using untreated controls. Statistical analysis was carried out using GraphPad
Prism version 7.04. The comparison of metabolic activity was evaluated by 2-way ANOVA
analysis with Dunnett’s test for multiple comparisons P values< 0.05 were considered statisti-
cally significant. Data was presented as means ± SEM (standard error of the mean).
Results
Characterization of PpIX@CD and PpIX-CD
CDs were synthesized utilizing microwave-assisted pyrolysis of a carbon source (citric acid or
sucrose), EDA functioning as both passivating agent and amine source. (Fig 1). The use of
ethylenediamine in CA-EDA and S-EDA CDs ensures the availability of primary amine func-
tional groups which can be used in cross-linking. The optimal temperature and time were
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determined to be 150˚C and 5 minutes respectively to prevent excessive formation of aggre-
gates. This methodology was utilized to produce CA-EDA (citric acid-based) and S-EDA
(sucrose-based) CDs.
Conjugates were synthesized with two distinct strategies (Fig 1). PpIX-CD was fabricated
with a modified cross-linking protocol which formed a covalent amide bond between the
amine groups of CA-EDA CDs and carboxylic acid groups of PPIX. PpIX@CD was success-
fully synthesized by a one-pot reaction of sucrose, EDA and PpIX, and was recovered as a dark
red liquid. An ultrasonic probe was used to thoroughly mix each solution prior to pyrolysis.
Purification was carried out in several steps throughout synthesis and cross-linking. We
recovered the less soluble fraction of the amide cross-linking solution, named (PpIX-CD)p,
with an increase of centrifugation time and speed. Dialysis with a 1 kDa MWCOmembrane
removed remaining contaminants from the CD and conjugate solutions. Freeze-drying pro-
duced a reddish to black powder which was subsequently weighed and stored in a dry environ-
ment away from light until used.
Transmission electron microscopy (TEM) revealed a quasispherical particle morphology
for all samples with an average diameter of 25 ± 10 nm (PpIX-CD) and 17 ± 6 nm (PpIX@CD)
(Fig 2). (PpIX-CD)p exhibited a highly variable particle size range of 15–100 nm. (S1 Fig).
Conjugates displayed an irregular quasispherical morphology, with aggregates forming regard-
less of the concentration and sample grid-loading combination that was tested. CA-EDA and
Fig 1. Synthesis routes utilized for CD-PS conjugates.Host-guest encapsulated (PPIX@CD) samples were produced in a one-pot reaction. CA-EDA CDs were used to
produce amide bond-linked (PPIX-CD and (PpIX-CD)p) conjugates. S-EDA CDs were embedded with PpIX in a one-pot encapsulation step.
https://doi.org/10.1371/journal.pone.0220210.g001
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S-EDA CDs showed an average particle size below 10 nm and a more defined spherical mor-
phology (S2 Fig). Finally, PpIX coalesced into well-defined geometric structures with sizes
greater than 100 nm in diameter. Our results show PpIX-CD and PpIX@CD form reduced
aggregates under 200 nm in size while both (PpIX-CD)p and PpIX quickly form aggregates.
Conjugates show reduced solubility in water in comparison to base CDs but are more soluble
than PpIX in concentrations below 25 μg/ml. Solutions with conjugates show slight precipita-
tion after several hours of ultrasonic processing.
We characterized the conjugates to determine similarities to PpIX. Fluorescence spectra
were obtained utilising conjugates suspended in PBS at pH 7 (Fig 3B) by matching the maxi-
mum excitation wavelength to the LED used for in vitro tests (ĕex = 405 nm). PpIX@CD was
compared to S-EDA CDs while PpIX@CD and (PpIX-CD)p were compared to CA-EDA CDs.
Fluorescence spectra demonstrate a dual emission behaviour from all conjugates. (Fig 3A and
3B) Carbon dot-related emissions are attenuated in conjugates, while PpIX-related emission
peaks>600 nm are very similar between all samples. (PpIX-CD)p showed greatly reduced
fluorescence to all samples in the range of 420–550 nm. PpIX loading in conjugates showed
various ratios: PpIX-CD (41%), (PpIX-CD)p (34%), and PpIX@CD (48%).
Infrared spectra obtained from PpIX and PpIX-CD were found to be nearly identical. Simi-
larly, this was observed between CA-EDA, S-EDA CDs, (PpIX-CD)p and PpIX@CD. FT-IR
spectroscopy was used to evaluate conjugate surface chemistry in the range of 4000–700 cm-1
(Fig 3C, 3D and S3 Fig). CA-EDA CDs were found to be very similar to S-EDA CDs, possibly
due to the similarity of their carbon sources. Peaks attributed to C-C stretching at 1680cm-1
Fig 2. CD-PS conjugates show decreased aggregation in water. TEM images of conjugates at 30,000× (top) and 68,000× (bottom). Conjugates show irregular
morphology and less aggregation in comparison to PpIX (30,000× top and 18,500× bottom).
https://doi.org/10.1371/journal.pone.0220210.g002
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can be seen in all samples. However, the small 1720 cm-1 peak corresponding to C = O stretch-
ing and the broad -OH peak at around 3000 cm-1 were not observed in PpIX-CD and PpIX. In
comparison, these peaks were seen in all other samples including PpIX@CD and (PpIX-CD)p.
Fig 3. Drug loading reduces CD-based photoluminescence and affects surface chemistry. CD-PpIX conjugates demonstrate dual emission at ĕex = 405 nm, with
quenching of CD-based photoluminescence (a,b). FT-IR demonstrated particles could be separated into two groups based on their similarities to PpIX and CD spectra (c,
d). The effect of amide cross-linking can be seen with the varying intensity of the amine band at 1570 cm-1.
https://doi.org/10.1371/journal.pone.0220210.g003
Carbon dot conjugates improve protoporphyrin IX efficiency
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The characteristic amide band can be observed in CD, (PpIX-CD)p and PpIX@CD around
1570 cm-1 and is absent in PpIX-CD. Peaks in the range of 1395–1216 cm1 can be ascribed to
C = C, C = N, and C = C-O respectively. The small sharp peaks at 1075 and 1059 cm-1 can be
seen in samples corresponding to C-O and C-H groups.
XPS analysis with survey and high resolution C1s scans determined conjugates have little to
no difference in surface composition with PpIX. Carbon dot compositions are very similar
between CA-EDA and S-EDA samples, with only slight variations in C and O. The pure PpIX
sample is close to what is expected given its chemical formula (C34H34N4O4). If hydrogens in
this sample are neglected, it has concentration values of 82.6 at% C, 8.2 at% N and 9.0 at% O,
as seen in Table 1. In comparison, CD conjugates demonstrate small increases in oxygen. The
high resolution C1s spectra peak positions are given relative to C-C/C-H being at ~285.0 eV,
and it is assumed the lowest carbon peak position is C-C/C-H as no carbides were expected in
these samples. (S1 Table) There was no distinction in peak position between both C-C and
C = C type bonds and are therefore expected to be the major peak.
Singlet oxygen production was determined by the time-resolved measurement of its charac-
teristic luminescence at 1270 nm (Fig 4). Samples were excited utilising a 355 nm Nd:YAG
laser at 50, 100, and 200 mJ. Phenalenone (PH) in dimethylformamide (DMF) was used as a
standard indicating 100% singlet oxygen production. PpIX was determined to produce an
average of 92.18% singlet oxygen. 1O2 production in conjugates was also calculated with values
of 63.79% (PpIX-CD), 77.10% (PpIX-CD)p and 51.62% PpIX@CD.
Evaluation of dark and light-activated toxicity
We evaluated the two parameters for determining conjugate cytotoxicity–dark toxicity (inher-
ent toxicity of the particles prior to light exposure) and light-activated toxicity. The average
lethal concentration at which metabolic activity is reduced by 50% (LD50) was estimated using
these concentrations. We also calculated the photo-toxicity index (PI) to make direct compari-
sons between conjugates and PpIX. The PI index links dark and light-activated toxicity–higher
PI values indicate greater efficiency with lower photoactivation LD50 concentrations and
increased dark toxicity resistance to PS. Cellular uptake and toxicity were evaluated in human
melanoma (C8161) cells using the Resazurin reduction assay to estimate metabolic activity.
DMEM-conjugate solutions over 10 μg/ml exhibited a distinct colour change from golden yel-
low to increasingly darker shades of red with the addition of both PpIX and conjugates.
Dark toxicity was reduced in all conjugates when the porphyrin is bound to the CDs.
CA-EDA and S-EDA CDs were used as controls for CD-induced toxicity and showed high
biocompatibility at concentrations over 100 μg/ml. Fig 5A shows a gradual decrease in meta-
bolic activity in proportion with conjugate concentration. We observed all conjugates exhib-
ited LD50 values (μg/ml) approximately 6-fold greater than free PpIX, with adjusted LD50
values over 3-fold higher than the drug alone. PpIX@CD exhibited the highest LD50 of all
Table 1. Surface composition (atomic%) of PpIX and CD-conjugates.
Sample C O N Na Cl
CA-EDA 56.7 37.4 5.8 <0.1 0.1
S-EDA 59.1 35.4 5.4 <0.1 0.1
PpIX 82.6 9.0 8.2 <0.1 0.2
PpIX-CD 81.6 9.6 8.6 <0.1 0.2
(PpIX-CD)p 76.4 13.5 9.7 <0.1 0.4
PpIX@CD 82.1 9.4 8.3 <0.1 0.2
https://doi.org/10.1371/journal.pone.0220210.t001
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samples while containing the highest PpIX concentration at 80.8 μMPpIX-adjusted (95.4 μg/
ml), compared to PpIX-CD (64 μMPpIX-adjusted, 88.5 μg/ml) and (PpIX-CD)p (60.3 μM
PpIX-adjusted, 100.5 μg/ml).
Light activated toxicity of conjugates demonstrated similar LD50 values between PpIX,
PpIX-CD and PpIX@CD (Fig 5C–5F). (PpIX-CD)p showed a significant difference from all
other samples with a reduced PDT effect at concentrations higher than 2.5 μg/ml. Incubation
with free PpIX induced significant light induced toxicity with an LD50 of 1.68 μM. Table 2
shows these values are similar to the PpIX-adjusted concentrations for PpIX-CD and
PpIX@CD (LD50 1.4 μM and 1.3 μM respectively). The photo-index (PI) of compounds was
calculated as the concentrations for dark toxicity divided by light toxicity. PpIX (μM) -CD and
PpIX@CD PI values were improved significantly from 14.6 to 46.6 and 59.6 respectively com-
pared to free PpIX.
Cell cultures were monitored for an additional (Fig 5E) 48 and (Fig 5F) 72 hours post light
exposure. Metabolic activity in vitro shows recovery at 48 and 72 hours post light exposure
regardless of conjugate type or concentration. We observed PpIX-CD and PpIX@CD followed
Fig 4. Singlet oxygen yield of conjugates in DMF. Corrected initial amplitude of lifetime generated singlet oxygen against the power of a 355 nm
Nd:YAG laser to calculate singlet oxygen yield of each sample. Phenalenone was used as a control for 95% production.
https://doi.org/10.1371/journal.pone.0220210.g004
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the same pattern as PpIX>1 μg/ml at all time points. However, (PpIX-CD)p continuously
exhibited decreased phototoxicity at all concentrations with high variability.
PpIX-CD and PpIX@CD exhibited increased PI values in comparison to PpIX, with a 2.8
and 3.5-fold increase. Both conjugates showed significant difference from PpIX�1 μg/ml (24
Fig 5. PpIX-CD and PpIX@CD decrease dark toxicity and produce an equivalent phototoxic effect to PpIX.
Metabolic activity was measured after 24 hours post-conjugate incubation. Dark toxicity was shown as particle
concentration (a) and total PpIX content (b). Light-activated toxicity was measured after a 3-minute time exposure in
embedded (c) and cross-linked (d) conjugates (ĕex = 405 nm, 2.78 mW/cm2). Further evaluation at 48 (e) and 72 (f)
hours show a recovery of metabolic activity in all samples.
https://doi.org/10.1371/journal.pone.0220210.g005
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hours) but did not show a significant difference at concentrations of>2.5 μg/ml in any time
point. We observed PDT efficiency was improved due to the decrease of dark toxicity of conju-
gates. In comparison, (PpIX-CD)p was found to have reduced PDT effect primarily due to its
low phototoxic effectiveness. Furthermore, this sample consistently showed a statistically sig-
nificant difference from light-activated PpIX at concentrations above 1 μg/ml.
Bioimaging of CD-PS conjugates
Confocal laser scanning microscopy (CSLM) was used to observe PpIX-CD and PpIX@CD
uptake and distribution in osteosarcoma cells (U2-OS) (Fig 6). CSLM images show all conju-
gates within cells distributed along the cytoplasm and cell nuclei. There are small differences
between the samples; PpIX-CD appears to have slightly more aggregates in comparison to
PpIX@CD. (PpIX-CD)p has a noticeably decreased fluorescence intensity in comparison to all
other samples and has a noticeably decreased emission at 488 and 543 nm. Conjugate concen-
tration appears to be higher near the nucleus for PpIX-CD and PpIX@CD. Z-stacks showed
both CDs and conjugates were localized near the nuclei in comparison to PpIX, which has no
specific location for accumulation. We observed rapid uptake of all conjugate samples at vari-
ous concentrations and time points.
Discussion
We selected microwave-assisted pyrolysis because of its adaptability, ease of use, and rapid
reaction time. In comparison, other protocols like hydrothermal synthesis or combustion are
more difficult to standardize. The reaction temperature (150˚C) and time (5 minutes) has pre-
viously been shown to be adequate for rapid CD synthesis with citric acid as a molecular pre-
cursor.[40] PpIX has greater thermal stability in comparison to the other reagents used for CD
synthesis (citric acid or sucrose, ethylenediamine). The majority of the molecular mass is
based on the pyrrole ring, which begins thermal decomposition around 360–450˚C as evi-
denced by TGA analysis. Although there is a slight mass reduction from 26–360˚C, this has
been mainly linked to the breaking of reactive bonds outside the ring [41]. Therefore, it is
highly likely host-guest embedding does not significantly alter PpIX structure and functional-
ity during microwave-assisted synthesis. Furthermore, the high thermal stability of the guest
molecule (PpIX) at the synthesis temperature suggests no other CDs are formed aside from
those obtained by sucrose and EDA pyrolysis.
We observed large ash-like aggregates formed during the carbonization of citric acid and
sucrose. Therefore, we adjusted the initial carbon source concentration and continuously stir-
red the solution throughout the process. The presence of precipitate in embedded carbon dots
Table 2. PpIX-CD conjugates improve PDT efficiency.
PpIX (%) Singlet Oxygen Dark Light PI
Sample Average
1O2 Yield
LD50
(μg/ml)
PpIX (μM) LD50
(μg/ml)
PpIX
(μM)
0 CA-EDA 0 >100 N/A 0 0 N/A
0 S-EDA 0 >100 N/A 0 0 N/A
100 PpIX 92.2 14.6 25.8 1.0 1.7 14.6
41 PpIX-CD 63.8 88.5 67.3 1.9 1.4 46.6
34 (PpIX-CD)p 77.1 100.5 94.2 7.2 4.3 13.9
48 PpIX@CD 51.6 95.4 59.9 1.6 1.3 59.6
Comparison of singlet oxygen yield, dark toxicity and light-activated efficiency of samples versus PpIX with measured and PPIX-adjusted values.
https://doi.org/10.1371/journal.pone.0220210.t002
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during microwave synthesis has been previously reported [36]. Although this fraction can be
removed through centrifugation or ultracentrifugation, a large quantity of the dopant is lost in
this step. We have observed that the use of a microwave reactor with stirring increases the total
quantity of PpIX that could be introduced efficiently with host-guest embedding is around 1
wt%. In comparison, previously reported embedded Nile Blue in PEG-based CDs used a 1:10
weight ratio and demonstrated a higher degree of aggregate formation, requiring centrifuga-
tion at 20,000 g and the use of an aqueous gel separation column to recover the sample [42].
Dialysis removed remaining compounds from synthesis and cross-linking such as polycyclic
aromatic compounds, buffer salts, and unbound PpIX [43].
Fig 6. CD-PS conjugates can be used as probes for fluorescence imaging. CSLM images of U2-OS osteosarcoma. PpIX-CD
and PpIX@CD have similar emissions to both CDs and PpIX, while (PpIX-CD)p has greatly decreased fluorescence emission.
Conjugates appear to aggregate near the nuclei.
https://doi.org/10.1371/journal.pone.0220210.g006
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EDC-NHS cross-linking ensures the directional cross-linking of CDs to PpIX and avoid the
formation of dimers. The standard protocol is that of protein cross-linking with an activation
buffer for the component with carboxyl groups (0.1 MMES, 0.5 M sodium chloride in deio-
nised water) at pH 6. However, PpIX has very low solubility in water and readily aggregated
when at low concentrations (<50 μg/ml). Yildiz et al. (2010) fabricated a similar conjugate
using a 50:50 DMSO/water solution to improve compound solubility prior to cross-linking
[44]. We experimented with water-miscible solvents for PpIX including acetone, DMSO, and
DMF. We determined DMF to be the most suitable solvent for cross-linking after several
trials.
TEM images demonstrate a size and morphology variation between conjugates. We specu-
late this is caused by the synthesis strategy and influences particle solubility. PpIX-CD was fab-
ricated in a controlled and directed cross-linking reaction utilising purified CA-EDA CDs and
PpIX. We also observed (PpIX-CD)p is the most heterogeneous sample with a wide size distri-
bution. Host-guest embedding relied on the one-pot synthesis of PpIX@CD which produced
slightly larger aggregates. CD nucleation and growth is altered by various synthesis conditions,
such as temperature and type of carbon source. This could be further affected by the use of
hydrophobic compounds and may have led to greater size variation in PpIX@CD compared to
PpIX-CD [45]. Therefore, host-guest embedding appears to be a less reliable and reproducible
strategy for drug loading in CDs in comparison to amide cross-linking.
A dual emission behaviour was observed in all conjugates with intense and broad emissions
at the 420–520 nm range similar to CD samples in literature [46]. Drug loading through both
amide cross-linking and embedding directly reduced CD fluorescence. This reduction is likely
caused by quenching of CD-based emissions through conjugate aggregation and obstruction
of surface defects, which have been reported to heavily contribute to CD photoluminescence
[47]. However, porphyrin-associated peaks to not seem to be greatly affected by either embed-
ding or amide cross-linking at its emission peaks at 617 and 677 nm. This is possibly due to its
outer location in the conjugate as PpIX binds to each CD. CDs typically have a strong and
broad absorption in the ultraviolet region, followed by a constant decrease as excitation wave-
length increases [48]. Absorption below 375 nm has been attributed to π–π� transitions of the
carbon dot surface, mainly from C = C and C = N bonds [49]. Carbon dot conjugates showed
great similarity to PpIX with an absorption peak evident at 405 nm. PpIX loading was calcu-
lated as stated in the literature by comparing the relative intensities of the 658 nm peak while
exciting the solution at ĕex = 404 nm [38]. The CD fluorescence was subtracted from each con-
jugate to estimate drug loading.
We divided conjugates as previously mentioned in two groups based on their similarities to
CDs or PpIX. The reduction of available amine functional groups during amide cross-linking
is likely the cause for variation between spectra. These slight variations between samples can
be observed particularly in the distinctive amide peak at ~1570 cm-1. The change in the avail-
ability of primary amines can also be seen in the region of 918–625 cm-1 which has been previ-
ously linked to N-H wag in carbon dots [50]. The assignment of peaks was carried out by
comparing IR spectra to those found in the literature for CD samples (S3 Table).
XPS analysis demonstrated there is little to no variation in the carbon envelopes of conju-
gates and PpIX. C = C bonds seen in the high resolution C1s spectra could present π-π� transi-
tions, which could lead to small intensities at higher binding energies but should not be
considered true XPS peaks. We observed that the C-N environment is the major component
and is seen at a higher binding energy and slightly reduced peak positions. This is possibly due
to the influence of carbons attached to nitrogen in PpIX and conjugates as it contains a por-
phine core with a tetrapyrrole macrocycle, giving it an aromatic nature [51].
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Singlet oxygen (O12) production alone initially indicates (PpIX-CD)p is the best conjugate
for PDT, while PpIX-CD and PpIX@CD appear to have reduced efficiency. However, this is
because DMF was required for the measurement. O12 yield was likely affected by the increased
solubility of (PpIX-CD)p in organic solvents, as this conjugate readily aggregates in water.
Nonetheless, we observed all the samples showed decreased singlet oxygen emission in com-
parison to PpIX. Our results indicate fluorescence emission intensity of the conjugates cannot
be directly linked to singlet oxygen yield.
CDs displayed extremely low toxicity with LD50 values (μg/ml) similar to previously
reported particles [52]. CA-EDA and S-EDA showed over 75%metabolic activity at concentra-
tions up to 250 μg/ml. In comparison, all PpIX-containing samples showed a sharp reduction
in metabolic activity over 50 μg/ml. Dark toxicity values of conjugates uniformly showed sta-
tistical difference from PpIX from concentrations�5 μg/ml (p< 0.05). The change from μg/
ml to PpIX-adjusted concentrations showed samples are capable of delivering higher quanti-
ties of PpIX without affecting the cells regardless of loading strategy. We speculate conjugate
toxicity may be influenced by solubility in an aqueous environment, incubation time, and cell
type. PpIX is a highly hydrophobic compound with approximately 1 μg/ml solubility in water
[53]. The decrease in dark toxicity of CD-based conjugates is likely a combination of more
innocuous intracellular localization and decreased formation of aggregates after uptake due to
the presence of cross-linked nanoparticles.
We observed light-activated toxicity in all samples. Additionally, we determined singlet
oxygen yield did is not directly linked to increased phototoxicity for CD conjugates. The control
PpIX showed no significant difference from PpIX-CD and PpIX@CD throughout various time
points and concentrations>1 μg/ml. Nonetheless, both samples showed increased efficiency as
an equivalent phototoxic effect was achieved utilising 36–42% loaded PpIX. We observed a 3.2
to 4.1-fold increase in photo-toxicity index (PI) compared to PpIX. The precipitate fraction
(PpIX-CD)p had previously shown a high singlet oxygen yield in DMF but failed to produce a
significant phototoxic effect in comparison to the control. It showed a reduced efficiency com-
pared to other PpIX-conjugates with a LD50 of 7.2 μg/ml (4.3 μMPpIX). (PpIX-CD)p also
showed a high degree of variation during light activation, which reduces its value as a photosen-
sitizer. Its diminished water solubility in comparison to PpIX-CDmay be caused by the forma-
tion of multiple covalent bonds during cross-linking leading to self-quenching.
Fowley et al. (2013) first reported the formation of a PpIX and CD conjugate with a Fo¨rster
resonance energy transfer (FRET) mechanism for enhanced PDT. In this study,the decreased
dark toxicity based on the increase of PpIX solubility was also observed with HeLa cells. Fur-
thermore, single and two-photon activation of the conjugates was reported [35]. Therefore, it
is possible an enhanced PDT effect could be produced by PpIX-CD and PpIX@CD due to the
same FRET mechanism using a lower wavelength for CD excitation or via two-photon irradia-
tion. Although the two-photon activation of conjugates is limited by the reduced area, two-
photon PDT is considered to be a highly promising future trend for research. This modality is
capable of a selective and highly targeted treatment for a wide variety of conditions such as
brain tumours, atherosclerosis, and other deep-seated cancers, while limiting damage to sur-
rounding healthy tissue. Although two-photon photosensitisers have been successfully fabri-
cated and evaluated in vitro, a considerable improvement is expected through the use of
vectors such as CDs for more efficient intracellular localisation.
The intracellular localization of conjugates may also benefit the action mechanism of singlet
oxygen. The intracellular accumulation of PpIX in mitochondria has been previously reported
based on its uptake by binding to a mitochondrial translocator protein involved in the heme
biosynthesis pathway [54]. Additionally, porphyrins have been shown to inhibit several impor-
tant mitochondrial enzymes leading to the inhibition of oxidative phosphorylation [55]. PpIX-
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based conjugates appear to follow these previously described interactions, with the advantage
of slightly increased water solubility due to the presence of CDs. However, the mechanism of
cell death after photoactivation of CD-PpIX conjugates is still unclear. PpIX-induced cell
death has been shown to be p53-dependent and independent; Zawacka-Pankau et al (2006)
proposed PpIX sensitizes cancer cells making them susceptible to PDT and disrupting prolifer-
ation through the destabilization of the HDM2-p53 complex in the mitochondria [56]. Our
results suggest that the variation of incubation time before light exposure may also influence
phototoxicity.
Hua et al. (2018) reported a similar conjugate based on the cross-linking of CDs and PpIX
with dicyclohexylcarbodiimide and 1-hydroxybenzotriazole (DCC/HOBt). They reported
increased cellular uptake and decreased toxicity prior to photoactivation. Interestingly, these
conjugates presented a similar size (25.2 ± 5.7 nm) to that of our cross-linked conjugate
(25 ± 10 nm), but lower PpIX loading efficiency of 23.3%, in comparison to 43.3% (PpIX-CD)
and 35.59% (PpIX@CD). Furthermore, they reported an intrinsic nucleolus-targeting capabil-
ity better than the only commercially-available dye SYTO RNASelect [57]. Although DCC has
some drawbacks such as the need for an organic solvent during cross-linking, it benefits from
the lack of hydrolysis during the reaction and low cost compared to EDC. DCC/HOBt cross-
linking has been used previously with CDs to conjugate photosensitizer Rose Bengal and the
mitochondria targeting moiety triphenylphosphonium [58,59]. Similarly, Zheng et al. (2016)
demonstrated efficient PDT with a carbon nitride (C3N4)-based multifunctional nanocompo-
site (PCCN) consisting of CDs, Arg-Gly-Asp motif, and PpIX. PCCN demonstrated water-
splitting ability to produce singlet oxygen production while in a state of hypoxia with a PpIX
content of 9.6%. [60] These studies further demonstrate the versatility of CDs as parts of
hybrid systems for efficient PDT.
CSLM images demonstrate PpIX, PpIX-CD and PpIX@CD are similar as bioimaging
probes and are mostly distributed along the cytoplasm, with strong emission at 543 nm excita-
tion. PpIX@CD demonstrates slightly reduced photoluminescence at 488 nm in comparison
to PpIX and PpIX-CD. Confocal z-stacks clearly show conjugates and PpIX do not enter the
nucleus but instead accumulate around the centre of the cell. Cancer cells have been shown to
have increased mitochondria in the perinuclear area, which is consistent with our observations
[61]. In comparison, CDs (CA-EDA and S-EDA) do not show significant fluorescence after
excitation at 543 nm but show some aggregates within the nucleus. We speculate this is due to
their decreased size and faster uptake in comparison to conjugates. Finally, (PpIX-CD)p shows
greatly reduced fluorescence emission with the 488 and 543 nm laser lines. This signal reduc-
tion could be caused by multiple factors. We have previously observed decreased fluorescence
intensity and rapid aggregation of (PpIX-CD)p, which has been shown to cause quenching as
carbon dots [62] and PpIX [12]. Our results indicate PpIX-CD and PpIX@CD are capable of
acting as high-contrast imaging probes without decreasing therapeutic efficiency for theranos-
tics applications.
Conclusion
PpIX was successfully encapsulated in carbon dots through one-pot microwave-assisted syn-
thesis, PpIX@CD. PPIX-CD and (PpIX-CD)p were synthesized through carbodiimide cross-
linking of CDs and PpIX. Host-guest embedding was shown to be a viable and cost-effective
alternative to carbodiimide cross-linking for loading PpIX and increasing photo-index. None-
theless, sample variability requires the optimization of synthesis conditions. PpIX loading in
carbon dot conjugates reduced CD-attributed photoluminescence and singlet oxygen genera-
tion in all conjugates regardless of drug loading percentage. Our results demonstrate host-
Carbon dot conjugates improve protoporphyrin IX efficiency
PLOS ONE | https://doi.org/10.1371/journal.pone.0220210 July 25, 2019 16 / 21
guest encapsulated PpIX@CD and carbodiimide-linked PpIX-CD conjugates produce similar
PDT effect to that of PpIX with a lower drug concentration, increasing the therapeutic window
of the compound. We expect CD-based conjugates to have significant value in biomedical
applications as carriers in PDT and PDD, as well as biomedical applications related to therag-
nostics, drug delivery, and bioimaging.
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